Cargando…

Advances of Heat Shock Family in Ulcerative Colitis

Ulcerative Colitis (UC) is a non-specific and chronic inflammatory disease of colonic mucosa whose exact etiology and mechanisms remain unclear. The incidence rate of UC is increasing year by year worldwide. What followed is that the medical costs are also rising rapidly. Therefore, it is urgent to...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Min, Zhang, Fengrui, Miao, Yinglei, Niu, Junkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133716/
https://www.ncbi.nlm.nih.gov/pubmed/35645809
http://dx.doi.org/10.3389/fphar.2022.869930
_version_ 1784713630617436160
author Gong, Min
Zhang, Fengrui
Miao, Yinglei
Niu, Junkun
author_facet Gong, Min
Zhang, Fengrui
Miao, Yinglei
Niu, Junkun
author_sort Gong, Min
collection PubMed
description Ulcerative Colitis (UC) is a non-specific and chronic inflammatory disease of colonic mucosa whose exact etiology and mechanisms remain unclear. The incidence rate of UC is increasing year by year worldwide. What followed is that the medical costs are also rising rapidly. Therefore, it is urgent to understand the pathogenesis and find promising therapeutic targets for UC. Intestinal mucosal homeostasis is essential for normal bowel function, and its imbalance may be an important pathogenesis of UC. Endogenous homeostatic regulators play roles in repairing intestinal mucosa injury after stress. Heat shock family proteins are essential endogenous homeostasis factors. They can inhibit inflammation, regulate intestinal epithelial cells’ survival and death, and promote mucosal healing. Thus, they play important roles in sustaining intestinal mucosal homeostasis and protecting against UC progression. However, the heat shock family may promote UC carcinogenesis. Here, we summarize the advances in the research of the functions of the heat shock family in UC. And this review is an attempt to light on the etiopathogenesis of UC, highlighting the endogenous protective mechanisms, hoping to provide a novel therapeutic target for UC treatment.
format Online
Article
Text
id pubmed-9133716
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91337162022-05-27 Advances of Heat Shock Family in Ulcerative Colitis Gong, Min Zhang, Fengrui Miao, Yinglei Niu, Junkun Front Pharmacol Pharmacology Ulcerative Colitis (UC) is a non-specific and chronic inflammatory disease of colonic mucosa whose exact etiology and mechanisms remain unclear. The incidence rate of UC is increasing year by year worldwide. What followed is that the medical costs are also rising rapidly. Therefore, it is urgent to understand the pathogenesis and find promising therapeutic targets for UC. Intestinal mucosal homeostasis is essential for normal bowel function, and its imbalance may be an important pathogenesis of UC. Endogenous homeostatic regulators play roles in repairing intestinal mucosa injury after stress. Heat shock family proteins are essential endogenous homeostasis factors. They can inhibit inflammation, regulate intestinal epithelial cells’ survival and death, and promote mucosal healing. Thus, they play important roles in sustaining intestinal mucosal homeostasis and protecting against UC progression. However, the heat shock family may promote UC carcinogenesis. Here, we summarize the advances in the research of the functions of the heat shock family in UC. And this review is an attempt to light on the etiopathogenesis of UC, highlighting the endogenous protective mechanisms, hoping to provide a novel therapeutic target for UC treatment. Frontiers Media S.A. 2022-05-12 /pmc/articles/PMC9133716/ /pubmed/35645809 http://dx.doi.org/10.3389/fphar.2022.869930 Text en Copyright © 2022 Gong, Zhang, Miao and Niu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Gong, Min
Zhang, Fengrui
Miao, Yinglei
Niu, Junkun
Advances of Heat Shock Family in Ulcerative Colitis
title Advances of Heat Shock Family in Ulcerative Colitis
title_full Advances of Heat Shock Family in Ulcerative Colitis
title_fullStr Advances of Heat Shock Family in Ulcerative Colitis
title_full_unstemmed Advances of Heat Shock Family in Ulcerative Colitis
title_short Advances of Heat Shock Family in Ulcerative Colitis
title_sort advances of heat shock family in ulcerative colitis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133716/
https://www.ncbi.nlm.nih.gov/pubmed/35645809
http://dx.doi.org/10.3389/fphar.2022.869930
work_keys_str_mv AT gongmin advancesofheatshockfamilyinulcerativecolitis
AT zhangfengrui advancesofheatshockfamilyinulcerativecolitis
AT miaoyinglei advancesofheatshockfamilyinulcerativecolitis
AT niujunkun advancesofheatshockfamilyinulcerativecolitis